Novozymes A/S
22.2.2021 15:14:03 CET | Globenewswire | Press release
Please read the full announcement in the attached PDF
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Investeringsforeningen C Worldwide20.3.2026 08:00:00 CET | Pressemeddelelse
Indkaldelse til ordinær generalforsamling i Investeringsforeningen C WorldWide
KH Group Oyj20.3.2026 07:45:00 CET | Press release
H Group Plc’s Financial Statements Release for 1 January – 31 December 2025: A strong end to 2025
Park Street A/S20.3.2026 07:14:15 CET | Press release
Park Street A/S: 2026 Strategy
VALLOUREC20.3.2026 07:00:00 CET | Press release
VALLOUREC TO SHOWCASE THE LATEST INNOVATIONS IN ITS VAM® CONNECTIONS AND COMPREHENSIVE SERVICE OFFERINGS AT OTC ASIA 2026
Novartis Pharma AG20.3.2026 07:00:00 CET | Press release
Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom